Kompella, Uday B.
University of Colorado Anschutz
7 papers on CoChatORCID 0000-0003-4341-9656
Most cited papers
- Verified
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
Trivedi, R., & Kompella, U. B. (2010) · Nanomedicine
Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems
Cited by 358
- Verified
Presenilin 1 Maintains Lysosomal Ca2+ Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification
Lee, J.-H., McBrayer, M. K., Wolfe, D. M., Haslett, L. J., Kumar, A., Sato, Y., Lie, P. P. Y., Mohan, P., Coffey, E. E., Kompella, U., et al. (2015) · Cell Reports
Calcium signaling and nucleotide metabolismAlzheimer's disease research and treatments
Cited by 358
- Verified
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery
Advanced Drug Delivery SystemsRetinal Diseases and Treatments
Cited by 257
- Verified
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H. (2021) · Drug Delivery and Translational Research
Advanced Drug Delivery SystemsOcular Infections and Treatments
Cited by 255
- Verified
Drug and Gene Delivery to the Back of the Eye: From Bench to Bedside
Rowe-Rendleman, C. L., Durazo, S. A., Kompella, U. B., Rittenhouse, K. D., Di Polo, A., Weiner, A. L., Grossniklaus, H. E., Naash, M. I., Lewin, A. S., Horsager, A., et al. (2014) · Investigative Opthalmology & Visual Science
Advanced Drug Delivery SystemsRetinal Diseases and Treatments
Cited by 120
- Verified
Preparation of large porous Deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process
Koushik, K., & Kompella, U. B. (2004) · Pharmaceutical Research
Advanced Drug Delivery SystemsPhase Equilibria and Thermodynamics
Cited by 86
- Verified
Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease
Cruz, N. M., Yuan, Y., Leehy, B. D., Baid, R., Kompella, U., DeAngelis, M. M., Escher, P., & Haider, N. B. (2014) · PLoS ONE
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 47
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free